Tower Research Capital LLC (Trc) Timber Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.1 - $0.3 $930 - $2,790	9,302 New	9,302 $1,000
Q1 2022 May 12, 2022	SELL	$0.28 - $0.41 $2,302 - $3,371	-8,222 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.38 - $0.89 $1,652 - $3,869	-4,348 Reduced 34.59%	8,222 $3,000
Q3 2021 Nov 15, 2021	BUY	$0.89 - $1.18 $10,386 - $13,770	11,670 Added 1296.67%	12,570 $11,000
Q2 2021 Aug 16, 2021	SELL	$1.06 - $2.25 $1,373 - $2,916	-1,296 Reduced 59.02%	900 $1,000
Q1 2021 May 17, 2021	BUY	$0.81 - $3.55 $1,778 - $7,795	2,196 New	2,196 $5,000
Q4 2020 Feb 16, 2021	SELL	$0.72 - $1.52 $678 - $1,431	-942 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.92 - $2.4 $866 - $2,260	942 New	942 $1,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.